The Paytm CEO's suggestions included constructing a giant observation wheel, similar to the iconic London Eye, which would ...

IIT BHU has achieved the highest CTC package of Rs 2,2 crore per annum in the recent placement session held at the institute.

That’s the concern raised by V. Ramgopal Rao, a noted academic and former director of IIT Delhi, in a recent post on X (formerly Twitter). Rao questioned DeepSeek about why India, despite ...

Team India's ace batter Virat Kohli returned to domestic cricket during Delhi's ongoing Ranji Trophy ... the star batter had covered the Team India logo with brown tape. It was done due to an ...

Kohli no longer lives in Delhi, or entirely in India, basing himself out of Mumbai and London; and as further incongruous reminder of his itineracy, the faithful threw themselves into un-ironical ...

In line with this strategy, Amazon has partnered with two of the country's most prominent literary events: Jaipur Literature Festival and New Delhi World Book Fair. These partnerships help Amazon ...

Aviral Jain (IIT BHU): A Computer Science graduate from IIT BHU, Aviral Jain secured a prestigious position at Walmart with a high-pay package. In 2019, he chose to renounce his corporate career ...

Recognising the growing demand for skilled professionals in this domain, the Indian Institute of Technology Delhi (IIT Delhi) has announced admissions to the third batch of its Executive Programme for ...

This is a fantastic car. It's amazing features like it's Steering wheel, Dashword,rear seats and exterior image had impressed me. It's outer look is dashing. I am impressed by this car. In my ...

Delhi Elections 2025 Live Updates: AAP national convener Arvind Kejriwal, while addressing a 'Jansabha' in East Delhi's Trilokpuri, urged the public to cast their votes "mindfully" in the upcoming ...

Tamil Nadu Congress Committee president K. Selvaperunthagai on Monday said that IIT Madras Director, Prof. Kamakoti, should not continue as the head of the premier technology institute in India ...

Jaguar Health’s (JAGX) Napo Pharmaceuticals and Napo Therapeutics announced that the first patient has been dosed in the independent investigator-initiated POC trial of crofelemer, Jaguar’s ...